192 related articles for article (PubMed ID: 30198905)
1. No recovery of replication-competent HIV-1 from human liver macrophages.
Kandathil AJ; Sugawara S; Goyal A; Durand CM; Quinn J; Sachithanandham J; Cameron AM; Bailey JR; Perelson AS; Balagopal A
J Clin Invest; 2018 Oct; 128(10):4501-4509. PubMed ID: 30198905
[TBL] [Abstract][Full Text] [Related]
2. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
3. Infectious Virus Persists in CD4
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy.
Ganor Y; Real F; Sennepin A; Dutertre CA; Prevedel L; Xu L; Tudor D; Charmeteau B; Couedel-Courteille A; Marion S; Zenak AR; Jourdain JP; Zhou Z; Schmitt A; Capron C; Eugenin EA; Cheynier R; Revol M; Cristofari S; Hosmalin A; Bomsel M
Nat Microbiol; 2019 Apr; 4(4):633-644. PubMed ID: 30718846
[TBL] [Abstract][Full Text] [Related]
5. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
[TBL] [Abstract][Full Text] [Related]
6. Brain macrophages harbor latent, infectious simian immunodeficiency virus.
Abreu C; Shirk EN; Queen SE; Beck SE; Mangus LM; Pate KAM; Mankowski JL; Gama L; Clements JE
AIDS; 2019 Dec; 33 Suppl 2(Suppl 2):S181-S188. PubMed ID: 31789817
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.
Soriano-Sarabia N; Bateson RE; Dahl NP; Crooks AM; Kuruc JD; Margolis DM; Archin NM
J Virol; 2014 Dec; 88(24):14070-7. PubMed ID: 25253353
[TBL] [Abstract][Full Text] [Related]
8. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
Buzon MJ; Martin-Gayo E; Pereyra F; Ouyang Z; Sun H; Li JZ; Piovoso M; Shaw A; Dalmau J; Zangger N; Martinez-Picado J; Zurakowski R; Yu XG; Telenti A; Walker BD; Rosenberg ES; Lichterfeld M
J Virol; 2014 Sep; 88(17):10056-65. PubMed ID: 24965451
[TBL] [Abstract][Full Text] [Related]
9. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.
DiNapoli SR; Ortiz AM; Wu F; Matsuda K; Twigg HL; Hirsch VM; Knox K; Brenchley JM
JCI Insight; 2017 Feb; 2(4):e91214. PubMed ID: 28239657
[TBL] [Abstract][Full Text] [Related]
10. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
11. HIV Persistence in Adipose Tissue Reservoirs.
Couturier J; Lewis DE
Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
[TBL] [Abstract][Full Text] [Related]
12. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
Ananworanich J; Dubé K; Chomont N
Curr Opin HIV AIDS; 2015 Jan; 10(1):18-28. PubMed ID: 25415421
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580.
Alamer E; Zhong C; Liu Z; Niu Q; Long F; Guo L; Gelman BB; Soong L; Zhou J; Hu H
J Virol; 2020 May; 94(11):. PubMed ID: 32188727
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.
Honeycutt JB; Wahl A; Archin N; Choudhary S; Margolis D; Garcia JV
Retrovirology; 2013 Oct; 10():121. PubMed ID: 24156277
[TBL] [Abstract][Full Text] [Related]
15. A high-throughput screening assay for silencing established HIV-1 macrophage infection identifies nucleoside analogs that perturb H3K9me3 on proviral genomes.
Yi Y; Zankharia U; Cassel JA; Lu F; Salvino JM; Lieberman PM; Collman RG
J Virol; 2023 Aug; 97(8):e0065323. PubMed ID: 37578230
[TBL] [Abstract][Full Text] [Related]
16. No evidence of HIV replication in children on antiretroviral therapy.
Van Zyl GU; Katusiime MG; Wiegand A; McManus WR; Bale MJ; Halvas EK; Luke B; Boltz VF; Spindler J; Laughton B; Engelbrecht S; Coffin JM; Cotton MF; Shao W; Mellors JW; Kearney MF
J Clin Invest; 2017 Oct; 127(10):3827-3834. PubMed ID: 28891813
[TBL] [Abstract][Full Text] [Related]
17. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
18. Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1.
Machado Andrade V; Stevenson M
J Neuroimmune Pharmacol; 2019 Mar; 14(1):33-43. PubMed ID: 29995208
[TBL] [Abstract][Full Text] [Related]
19. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
[TBL] [Abstract][Full Text] [Related]
20. CD161
Li X; Liu Z; Li Q; Hu R; Zhao L; Yang Y; Zhao J; Huang Z; Gao H; Li L; Cai W; Deng K
mBio; 2019 Oct; 10(5):. PubMed ID: 31594817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
